Additional file 6 of Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
Additional file 6: Figure S2. Laboratory Values. Medians are represented by triangles, with an upward point for Zilucoplan and a downward point for Control, respectively. CRP, C-reactive protein; LDH, lactate dehydrogenase.